Login
retatrutide triple agonist gip glp-1 glucagon receptor retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter
retatrutide triple agonist gip glp-1 glucagon receptor retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter
retatrutide triple agonist gip glp-1 glucagon receptor retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter
 Next

retatrutide triple agonist gip glp-1 glucagon receptor retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter

Marsoni M251S
Sale price$21.02
Pay 4 payments of $5.25 a month.Shop Pay
Get it in 3 business days with 1 day shipping. Friday, May 29
Crystal Structure of Glucagon like Peptide 1 in Complex with the Extracellular Domain of the Glucagon like Peptide 1 Receptor ScienceDirect Side Effect Profile of GLP 1 Agonists HOT OFF THE PRESS: Retatrutide Phase 3 data has arrived and the obesity medicine world is paying attention. In Lilly's TRIUMPH 1 trial, participants receiving the highest dose achieved an average Diabetes Patients Also Struggle to Access GLP 1 Agonists MedPage Today
Easy Shipping

Quick Dispatch:

Your retatrutide triple agonist gip glp-1 glucagon receptor retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter orders ship within 1-2 business days.

Delivery Options:

  • Standard: 3-7 business days
  • Fast: 2-3 business days
  • Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your retatrutide triple agonist gip glp-1 glucagon receptor retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter ships.

Need Help?
Questions about retatrutide triple agonist gip glp-1 glucagon receptor retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for retatrutide triple agonist gip glp-1 glucagon receptor retatrutide is a novel triple agonist peptide at the glucagon receptor, GIP receptor, and GLP-1 receptor. 22-24% weight loss at 48 weeks with a similar tolerability profile to #tirzepatide. @LillyPad #medtwitter #endotwitter in your area.

Get Shipping Estimates

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy
4.7 ★★★★★
Based on 447 reviews
Sort
Highest Rating
Newest First
Oldest First
Product Reviews
A
Verified Purchase
Alleged Lee
Port Orchard, US
★★★★★ 4
Nice, lightweight blanket for cool rooms. Probably a bit light for a COLD room.
Color: Dark Grey, Size: Queen
This is a nice soft lightweight blanket. The only problem I have is they don't come in a "standard" mattress size, so you order something that may (does in my case) touch the floor. I'd have said they drag the floor, but that only happens when you move the bed around the room with the blanket in place. An unhandy way to clean the floor, so I don't recommend it.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 22, 2026
W
Verified Purchase
Wendy Adkins
Houston, US
★★★★★ 5
Incredible purchase
Color: White, Size: King
Beautiful and lightweight. Adds texture to any bedding. It is a warm ivory color.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 6, 2026
P
Verified Purchase
Patricia Hurt
Lexington, US
★★★★★ 5
Summer perfect! Soft and light
Color: White, Size: Twin
I bought 3. As soon as I opened the bag there was an odor to them. They didn’t feel like made with natural products. I washed them & when they came out of the dryer they smelled good & are so soft. I will order other colors.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 8, 2026
B
Verified Purchase
Brandon Gabriel
Lake Worth, US
★★★★★ 2
Impossible to keep clean
Color: White, Size: Queen, Color: White, Size: Queen
Great blanket. How TF are you supposed to keep it clean? They provide garment bag, but my zipper broke before I could even use it. I had one of these before and my ex lost the bag, so I had no idea it even came with one. These rip and get burned in the dryer. DON’T WASTE YOUR MONEY
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 10, 2026
L
Verified Purchase
Lisa
Los Angeles, US
★★★★★ 5
Soft and perfect for warmer days
Color: White, Size: Queen, Color: White, Size: Queen
Soft and I love the waffle design just get it perfect for warmer days. It’s not too light therefore still gives some warmth.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 5, 2026

recommand products

FDA Ends Semaglutide Shortage Listing, Contributing to Ongoing Legal Challenges
FDA Ends Semaglutide Shortage Listing, Contributing to Ongoing Legal Challenges
24.51
 As of February 21, 2025, the FDA updated its drug shortage list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A
As of February 21, 2025, the FDA updated its drug shortage list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A
20.82
 Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s
Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s
24.18
 FDA declares semaglutide shortage over
FDA declares semaglutide shortage over
22.78
 Wegovy FDA Approval: CV Risk and Weight Management in Obesity
Wegovy FDA Approval: CV Risk and Weight Management in Obesity
26.45